IOL CHEMICALS & PHARM. | NUTRAPLUS PR | IOL CHEMICALS & PHARM./ NUTRAPLUS PR |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.1 | -0.1 | - | View Chart |
P/BV | x | 1.5 | 0.3 | 450.2% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. NUTRAPLUS PR |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
NUTRAPLUS PR Mar-20 |
IOL CHEMICALS & PHARM./ NUTRAPLUS PR |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 22 | 2,451.8% | |
Low | Rs | 272 | 5 | 5,078.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 25.6 | 1,474.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | -14.0 | -168.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -12.7 | -249.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 6.3 | 4,050.4% | |
Shares outstanding (eoy) | m | 58.71 | 34.09 | 172.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.5 | 201.4% | |
Avg P/E ratio | x | 17.1 | -1.0 | -1,757.0% | |
P/CF ratio (eoy) | x | 12.8 | -1.1 | -1,189.6% | |
Price / Book Value ratio | x | 1.6 | 2.1 | 73.3% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 464 | 5,111.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 73 | 2,292.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 873 | 2,538.5% | |
Other income | Rs m | 256 | 1 | 17,909.1% | |
Total revenues | Rs m | 22,427 | 875 | 2,563.6% | |
Gross profit | Rs m | 2,257 | -358 | -629.7% | |
Depreciation | Rs m | 462 | 47 | 981.9% | |
Interest | Rs m | 165 | 74 | 221.6% | |
Profit before tax | Rs m | 1,887 | -478 | -394.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | - | |
Profit after tax | Rs m | 1,391 | -478 | -290.9% | |
Gross profit margin | % | 10.2 | -41.0 | -24.8% | |
Effective tax rate | % | 26.2 | 0 | - | |
Net profit margin | % | 6.3 | -54.8 | -11.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 178 | 5,432.4% | |
Current liabilities | Rs m | 5,025 | 890 | 564.7% | |
Net working cap to sales | % | 20.9 | -81.5 | -25.7% | |
Current ratio | x | 1.9 | 0.2 | 962.0% | |
Inventory Days | Days | 43 | 1 | 6,694.3% | |
Debtors Days | Days | 8 | 11,562,625 | 0.0% | |
Net fixed assets | Rs m | 11,017 | 939 | 1,173.8% | |
Share capital | Rs m | 587 | 170 | 344.4% | |
"Free" reserves | Rs m | 14,490 | 46 | 31,713.9% | |
Net worth | Rs m | 15,077 | 216 | 6,975.7% | |
Long term debt | Rs m | 0 | 2 | 0.0% | |
Total assets | Rs m | 20,684 | 1,117 | 1,852.5% | |
Interest coverage | x | 12.5 | -5.4 | -229.1% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.8 | 137.0% | |
Return on assets | % | 7.5 | -36.2 | -20.8% | |
Return on equity | % | 9.2 | -221.3 | -4.2% | |
Return on capital | % | 13.6 | -185.1 | -7.3% | |
Exports to sales | % | 26.7 | 1.3 | 2,074.7% | |
Imports to sales | % | 0 | 0.7 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 11 | 52,665.2% | |
Imports (cif) | Rs m | NA | 6 | 0.0% | |
Fx inflow | Rs m | 5,930 | 11 | 52,665.2% | |
Fx outflow | Rs m | 6,052 | 6 | 101,031.7% | |
Net fx | Rs m | -122 | 5 | -2,309.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 91 | 1,348.1% | |
From Investments | Rs m | -1,200 | -27 | 4,467.6% | |
From Financial Activity | Rs m | -41 | -76 | 54.3% | |
Net Cashflow | Rs m | -18 | -12 | 155.5% |
Indian Promoters | % | 48.2 | 40.1 | 120.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | 5,666.7% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 59.9 | 86.5% | |
Shareholders | 130,003 | 7,943 | 1,636.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | NUTRAPLUS PR | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.59% | 5.00% | -0.67% |
1-Month | -4.90% | 9.95% | 1.92% |
1-Year | -4.49% | -60.67% | 49.47% |
3-Year CAGR | -12.13% | -52.30% | 14.12% |
5-Year CAGR | 15.26% | -40.89% | 19.14% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the NUTRAPLUS PR share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of NUTRAPLUS PR the stake stands at 40.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of NUTRAPLUS PR.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
NUTRAPLUS PR paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of NUTRAPLUS PR.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.